Detalhe da pesquisa
1.
Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry.
Rheumatology (Oxford)
; 62(2): 804-814, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35703945
2.
Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus.
Clin Exp Rheumatol
; 41(1): 186-194, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36135940
3.
Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study.
J Clin Rheumatol
; 28(5): 270-277, 2022 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35653615
4.
Causal pathways to health-related quality of life in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort.
Rheumatology (Oxford)
; 60(10): 4691-4702, 2021 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33506861
5.
Teens Taking Charge: A Randomized Controlled Trial of a Web-Based Self-Management Program With Telephone Support for Adolescents With Juvenile Idiopathic Arthritis.
J Med Internet Res
; 22(7): e16234, 2020 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32723728
6.
Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care.
BMC Health Serv Res
; 19(1): 572, 2019 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31412858
7.
Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis: Results Through Week 52 of the GO-ALIVE Study.
J Clin Rheumatol
; 28(8): 420-423, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35649533
8.
Validation of administrative health data for the pediatric population: a scoping review.
BMC Health Serv Res
; 14: 236, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24885035
9.
Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
ACR Open Rheumatol
; 6(5): 304-311, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417434
10.
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study.
RMD Open
; 10(1)2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531621
11.
Work Productivity and General Health Through 2 Years of Guselkumab Treatment in a Phase 3 Randomized Trial of Patients With Active Psoriatic Arthritis.
Rheumatol Ther
; 11(2): 425-441, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38386178
12.
Response to Treatment with Intravenous Golimumab or Infliximab in Rheumatoid Arthritis Patients: PROMIS Results from the Real-World Observational Phase 4 AWARE Study.
Rheumatol Ther
; 10(3): 659-678, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36820983
13.
Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort.
Pediatr Rheumatol Online J
; 21(1): 102, 2023 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715224
14.
Effectiveness and safety of intravenous golimumab with and without concomitant methotrexate in patients with rheumatoid arthritis in the prospective, noninterventional AWARE study.
BMC Rheumatol
; 7(1): 5, 2023 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36973741
15.
Effect of Intravenous Golimumab on Fatigue and the Relationship with Clinical Response in Adults with Active Ankylosing Spondylitis in the Phase 3 GO-ALIVE Study.
Rheumatol Ther
; 10(4): 983-999, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322274
16.
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Rheumatol Ther
; 10(6): 1479-1501, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37597159
17.
Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry.
Clin Rheumatol
; 41(8): 2319-2327, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35312895
18.
Effectiveness and Safety of High-Dose Biologics in Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance.
Arthritis Care Res (Hoboken)
; 74(11): 1770-1779, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34121344
19.
Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapolation of Data from Studies in Adults and Adjacent Pediatric Populations.
Paediatr Drugs
; 24(6): 699-714, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171515
20.
Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
Drugs Real World Outcomes
; 9(4): 617-628, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36243860